These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16229763)

  • 1. Fluoroquinolone-resistant Escherichia coli, Indonesia.
    Kuntaman K; Lestari ES; Severin JA; Kershof IM; Mertaniasih NM; Purwanta M; Hadi U; Johnson JR; van Belkum A; Verbrugh HA;
    Emerg Infect Dis; 2005 Sep; 11(9):1363-9. PubMed ID: 16229763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virulence genotypes and phylogenetic background of fluoroquinolone-resistant and susceptible Escherichia coli urine isolates from dogs with urinary tract infection.
    Johnson JR; Kuskowski MA; Owens K; Clabots C; Singer RS
    Vet Microbiol; 2009 Apr; 136(1-2):108-14. PubMed ID: 19019576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between virulence profile and fluoroquinolone resistance in Escherichia coli isolated from dogs and cats in China.
    Liu X; Liu H; Li Y; Hao C
    J Infect Dev Ctries; 2017 Apr; 11(4):306-313. PubMed ID: 28459221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended-spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans.
    Johnson JR; Kuskowski MA; Owens K; Gajewski A; Winokur PL
    J Infect Dis; 2003 Sep; 188(5):759-68. PubMed ID: 12934193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prominence of an O75 clonal group (clonal complex 14) among non-ST131 fluoroquinolone-resistant Escherichia coli causing extraintestinal infections in humans and dogs in Australia.
    Platell JL; Trott DJ; Johnson JR; Heisig P; Heisig A; Clabots CR; Johnston B; Cobbold RN
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3898-904. PubMed ID: 22526317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of host and bacterial virulence factors in Escherichia coli spontaneous bacterial peritonitis.
    Cereto F; Herranz X; Moreno E; Andreu A; Vergara M; Fontanals D; Roget M; Simó M; González A; Prats G; Genescà J
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):924-9. PubMed ID: 18794608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal group distribution of fluoroquinolone-resistant Escherichia coli among humans and companion animals in Australia.
    Platell JL; Cobbold RN; Johnson JR; Trott DJ
    J Antimicrob Chemother; 2010 Sep; 65(9):1936-8. PubMed ID: 20570998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli.
    Moreno E; Prats G; Sabaté M; Pérez T; Johnson JR; Andreu A
    J Antimicrob Chemother; 2006 Feb; 57(2):204-11. PubMed ID: 16390858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phylogenetic background and virulence profiles of fluoroquinolone-resistant clinical Escherichia coli isolates from the Netherlands.
    Johnson JR; van der Schee C; Kuskowski MA; Goessens W; van Belkum A
    J Infect Dis; 2002 Dec; 186(12):1852-6. PubMed ID: 12447775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular epidemiology and genetic diversity of fluoroquinolone-resistant Escherichia coli isolates from patients with community-onset infections in 30 Chinese county hospitals.
    Zhao L; Zhang J; Zheng B; Wei Z; Shen P; Li S; Li L; Xiao Y
    J Clin Microbiol; 2015 Mar; 53(3):766-70. PubMed ID: 25520451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geographic distribution of fluoroquinolone-resistant Escherichia coli strains in Asia.
    Uchida Y; Mochimaru T; Morokuma Y; Kiyosuke M; Fujise M; Eto F; Harada Y; Kadowaki M; Shimono N; Kang D
    Int J Antimicrob Agents; 2010 Apr; 35(4):387-91. PubMed ID: 20138480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MECHANISMS OF RESISTANCE TO CIPROFLOXACIN AND GENETIC DIVERSITY OF ESCHERICHIA COLI STRAINS ORIGINATING FROM URINE CULTURES PERFORMED FOR ROMANIAN ADULTS.
    Cristea VC; Oprea M; Neacşu G; Gîlcă R; Popa MI; Usein CR
    Roum Arch Microbiol Immunol; 2015; 74(3-4):73-8. PubMed ID: 27328520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoroquinolone-resistant extraintestinal Escherichia coli clinical isolates representing the O15:K52:H1 clonal group from humans and dogs in Australia.
    Platell JL; Cobbold RN; Johnson JR; Clabots CR; Trott DJ
    Comp Immunol Microbiol Infect Dis; 2012 Jul; 35(4):319-24. PubMed ID: 22385907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea.
    Lee MY; Choi HJ; Choi JY; Song M; Song Y; Kim SW; Chang HH; Jung SI; Kim YS; Ki HK; Son JS; Kwon KT; Heo ST; Yeom JS; Shin SY; Chung DR; Peck KR; Song JH; Ko KS
    J Infect; 2010 Feb; 60(2):146-53. PubMed ID: 19932131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of fluoroquinolone-resistant Escherichia coli O25:H4-ST131 (CTX-M-15-nonproducing) strains isolated in Japan.
    Yokota S; Sato T; Okubo T; Ohkoshi Y; Okabayashi T; Kuwahara O; Tamura Y; Fujii N
    Chemotherapy; 2012; 58(1):52-9. PubMed ID: 22343392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phylogenetic background and virulence genotype of ciprofloxacin-susceptible and ciprofloxacin-resistant Escherichia coli strains of human and avian origin.
    Graziani C; Luzzi I; Corro M; Tomei F; Parisi G; Giufre M; Morabito S; Caprioli A; Cerquetti M
    J Infect Dis; 2009 Apr; 199(8):1209-17. PubMed ID: 19226230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey of plasmid-mediated fluoroquinolone resistance genes from Escherichia coli isolates and their dissemination in Shandong, China.
    Xia LN; Li L; Wu CM; Liu YQ; Tao XQ; Dai L; Qi YH; Lu LM; Shen JZ
    Foodborne Pathog Dis; 2010 Feb; 7(2):207-15. PubMed ID: 19911944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of cross-resistance to aminoglycosides in fluoroquinolone-resistant Escherichia coli clinical isolates.
    Tsukamoto N; Ohkoshi Y; Okubo T; Sato T; Kuwahara O; Fujii N; Tamura Y; Yokota S
    Chemotherapy; 2013; 59(5):379-84. PubMed ID: 24852043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal trends in fluoroquinolone resistance among Enterobacteriaceae isolates from inpatients and outpatients, 1989-2000: differences in the emergence and epidemiology of resistance across organisms.
    Lautenbach E; Strom BL; Nachamkin I; Bilker WB; Marr AM; Larosa LA; Fishman NO
    Clin Infect Dis; 2004 Mar; 38(5):655-62. PubMed ID: 14986249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of Romanian fluoroquinolone-resistant human clinical Escherichia coli isolates.
    Usein CR; Tatu-Chiţoiu D; Nica M; Ciontea SA; Palade AM; Condei M; Damian M
    Roum Arch Microbiol Immunol; 2008; 67(1-2):23-9. PubMed ID: 19284163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.